Sundaram Pharma Private Limited
About Sundaram Pharma Private Limited
Data last updated:
Sundaram Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 09 November 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51397MH2004PTC149475. Its GSTIN is 27AAICS5826K1ZV (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.5 Lakh. It is led by directors including Dhroov Dinesh Singh and Dinesh Amar Bahadur Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 4/6 Laxmi Bhuvanbora Bazar Street Fort, Mumbai, Maharashtra, India – 400001.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.79 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹2.91 Cr (net margin 50.3%) and EBITDA of ₹4.37 Cr (EBITDA margin 75.4%). Revenue has grown at a compounded annual rate (CAGR) of 40% over three years and 90% over five years.
As per MCA filings, the company has open charges of ₹8.49 Cr on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
Company details
Contact details
Sundaram Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address4/6 Laxmi Bhuvanbora Bazar Street Fort, Mumbai, Maharashtra, India – 400001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Sundaram Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sundaram Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sundaram Pharma Private Limited, buy the company report.
Financials of Sundaram Pharma Private Limited
FY 2025 filings availableSundaram Pharma Private Limited reported revenue of ₹5.79 Cr (up 17% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 90% over five years, including 17% growth in the latest year. EBITDA rose 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.37 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.91 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 75.4% | ||||
| Net Profit Margin | 50.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sundaram Pharma Private Limited, buy the company report.
Board of directors of Sundaram Pharma Private Limited
Sundaram Pharma has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dhroov Dinesh Singh Also directs: Satyam Generic Pharma Private Limited | Director | 15 Mar 2022 | 4 Years 7 Months | Current |
| Dinesh Amar Bahadur Singh | Director | 01 May 2023 | 3 Years 5 Months | Current |
| Brijesh Amar Bahadur Singh | Director | 09 Nov 2004 | 21 Years 11 Months | Current |
Peer comparison
Sundaram Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aquinnova Healthcare Private Limited | ₹5.81 Cr (FY 2024) | 25.0% | Bhiwandi, Maharashtra, India | |||
| Maryus Healthcare Private Limited | ₹5.81 Cr (FY 2025) | -36.0% | Mumbai, Maharashtra, India | |||
| Next Gen Pharma India Private Limited | ₹5.8 Cr (FY 2023) | -30.0% | Delhi, India | |||
| De Harbien Life Sciences Private Limited | ₹5.8 Cr (FY 2025) | 9.0% | Thiruvananthapuram, Kerala, India | |||
| Sundaram Pharma Private Limitedthis company | ₹5.79 Cr (FY 2025) | ₹2.91 Cr | 50.3% | 17.0% | Mumbai, Maharashtra, India | |
| Dixit Distributors Private Limited | ₹5.77 Cr (FY 2025) | -17.0% | Uttar Pradesh, India |
To see the full peer comparison of Sundaram Pharma Private Limited, buy the company report.
Auditor
Sundaram Pharma Private Limited is audited by K. P. DODECHA & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K. P. DODECHA & CO. | FY 2023 | 119485W |
Shareholding
The shareholding of Sundaram Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sundaram Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 May 2025 | 101114365 | Others | ₹4.99 Cr | Open | |
| 08 Apr 2024 | 100925143 | Others | ₹3.5 Cr | Open |
Total charge records: 2 View all charges
Legal cases
Sundaram Pharma Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Court case (SMST R) | Filed against the company by Zoetic Ayurvedics Pvt. Ltd | Pending |
To see the full case history of Sundaram Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sundaram Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sundaram Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICS5826K1ZV | Maharashtra | Active | 09 Jun 2021 |
To see the full GST registrations and return filing status of Sundaram Pharma Private Limited, buy the company report.
Recent activity
Sundaram Pharma Private Limited has 7 board changes on record since 2004: 3 appointments and 4 cessations. The latest: Dinesh Amar Bahadur Singh was appointed as Director on 01 May 2023.
Frequently asked questions
Sundaram Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 09 November 2004 (22+ years old) and is registered under CIN U51397MH2004PTC149475.
Sundaram Pharma has 3 current directors:
- Dhroov Dinesh Singh - Director
- Dinesh Amar Bahadur Singh - Director
- Brijesh Amar Bahadur Singh - Director
The latest financial statements of Sundaram Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sundaram Pharma is 27AAICS5826K1ZV, registered in Maharashtra.
The CIN (Corporate Identification Number) of Sundaram Pharma is U51397MH2004PTC149475. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sundaram Pharma has 1 court case on record: 1 filed against it. 1 is pending.
Sundaram Pharma was incorporated on 09 November 2004, making it 22+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Sundaram Pharma by revenue are Aquinnova Healthcare Private Limited, Maryus Healthcare Private Limited, Next Gen Pharma India Private Limited, De Harbien Life Sciences Private Limited, Dixit Distributors Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Dinesh Amar Bahadur Singh was appointed as Director on 01 May 2023. Dhroov Dinesh Singh ceased to be Additional Director on 14 Mar 2023. Dhroov Dinesh Singh was appointed as Director on 15 Mar 2022. Sundaram Pharma has 7 board changes on record in total.
The registered office of Sundaram Pharma is at 46 Laxmi Bhuvanbora Bazar Street Fort, Mumbai, Maharashtra, India – 400001.
Sundaram Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.